Hilary A. Capell
- Rheumatology top 0.2%
- Rheumatoid Arthritis Research and Therapies 16
- Systemic Lupus Erythematosus Research 5
- Hematology top 2%
- Autoimmune and Inflammatory Disorders Research 3
- Immunology top 5%
- Genetics top 5%
-
- Inflammatory mediators and NSAID effects 3
- Drug-Induced Adverse Reactions 2
- Pharmacological Effects of Natural Compounds 2
-
- Pain Mechanisms and Treatments 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- David McCareyIain B. McInnesNaveed SattarPeter LockW. KincaidA. StirlingDuncan PorterAlex D. McMahon
- Cited by
- RheumatologyHematologyImmunology
- Journals
- The Lancet (3 papers)Biochemical Society Transactions (1 paper)Current Medical Research and Opinion (1 paper)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Hilary A. Capell
22 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Rheumatology 1.9k
- Hematology 582
- Immunology 527
- Genetics 264
- Pathology and Forensic Medicine 311
Countries citing papers authored by Hilary A. Capell
This map shows the geographic impact of Hilary A. Capell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilary A. Capell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilary A. Capell more than expected).
Fields of papers citing papers by Hilary A. Capell
This network shows the impact of papers produced by Hilary A. Capell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilary A. Capell. The network helps show where Hilary A. Capell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hilary A. Capell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 3 | |
| 2 | 2007 | 63 | |
| 3 | Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trialbreakdown → | 2004 | 1029 |
| 4 | Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trialbreakdown → | 2004 | 612 |
| 5 | 2003 | 20 | |
| 6 | Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritisbreakdown → | 2003 | 707 |
| 7 | 2003 | 1 | |
| 8 | "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy. | 2002 | 6 |
| 9 | Longterm maintenance therapy with disease modifying antirheumatic drugs. | 2002 | 3 |
| 10 | 2001 | 3 | |
| 11 | The hip or not. | 2001 | 1 |
| 12 | 2001 | 11 | |
| 13 | 2000 | 11 | |
| 14 | 1988 | 2 | |
| 15 | 1985 | 1 | |
| 16 | 1983 | 4 | |
| 17 | 1983 | 130 | |
| 18 | 1978 | 13 | |
| 19 | 1977 | 3 | |
| 20 | 1976 | 4 |
About Hilary A. Capell
Hilary A. Capell is a scholar working on Rheumatology, Hematology, Pharmacology, Pharmacology and Genetics, having authored 22 papers that have together received 2.6k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (16 papers), Systemic Lupus Erythematosus Research (5 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Inflammatory mediators and NSAID effects (3 papers), Pain Mechanisms and Treatments (2 papers), Drug-Induced Adverse Reactions (2 papers), Pharmacological Effects of Natural Compounds (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Rheumatology (1.9k citations), Hematology (582 citations), Immunology (527 citations), Genetics (264 citations) and Pathology and Forensic Medicine (311 citations). Hilary A. Capell has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include David McCarey, Iain B. McInnes, Naveed Sattar, Peter Lock, W. Kincaid, A. Stirling, Duncan Porter, Alex D. McMahon, R. Vallance and Rajan Madhok. Their work appears in journals such as The Lancet, Biochemical Society Transactions, Current Medical Research and Opinion, QJM and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.